CIK: 1754937 - Address: C/O Artiva Biotherapeutics, Inc., 5505 Morehouse Drive, Suite 100, San Diego, CA 92121
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/17/22 17:58
3/15/22
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMoore AlisonCAOChief TeS-667.630-9-7120D
3/17/21 17:00
3/15/21
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMoore AlisonCAOChief TeS-23538.140-6-6103D
10/13/20 16:34
10/12/20
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMoore AlisonCAOChief TeS.dm-1,48142.000-35-25108D
10/9/20 17:49
10/8/20
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMoore AlisonCAOChief TeS.dm-1,82841.000-45-29108D
10/8/20 17:03
10/6/20
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMoore AlisonCAOChief TeS.d-1,78340.000-45-27118D
3/18/20 16:32
3/16/20
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMoore AlisonCAOChief TeS-7219.190-4-663D
9/18/19 19:05
9/16/19
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMoore AlisonCAOChief TeS.dm-1,56832.110-49-4266D
7/30/19 18:23
7/26/19
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMoore AlisonCAOChief TeS.dm-1,43829.440-49-4365D
6/5/19 17:49
6/3/19
ALLOAllogene Therapeutics, Inc.HealthBioPrdBiological Products, (No DiagMoore AlisonCAOChief TeS.d-1,30726.760-49-5738D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact